Research Decoder: Outcome measures I – Clinical
Clinical trials are an indispensable part of the process that determines which disease-treating interventions (including drugs, procedures, technologies, or lifestyle modifications) can move…
A triumph of teamwork and collaboration: MSSRF awards 3.2M to Canadian pediatric MS research group
Thinking back to my days in the lab, one thing that sticks out in my mind is the importance of teamwork. Collaborative research…
We want to hear from you!
The Canadian Agency for Drugs and Technologies in Health (CADTH) is conducting a drug review for an MS treatment called peginterferon beta-1a. Marketed as Plegridy(TM) by Biogen, this drug…
Research Decoder: Biomarkers
The term “biomarker” is a popular buzzword in the biomedical research world, and for good reason. Biomarkers are an indispensable part of the…
A new gateway between the immune system and the brain?
Last week, a study published in the prestigious journal Nature made waves in the scientific community with the discovery of a direct connection…
Research Decoder: Comorbidities
A comorbidity is a chronic medical condition that occurs alongside an existing one. For example, someone diagnosed with both multiple sclerosis and hypertension…
World MS Day: Breaking down barriers for people living with MS
Today is World MS Day, a day for people around the world to take action, share stories, raise awareness and campaign with and…
MS Research Town Hall: Pre-Interview pt III with Dr. Helen Genova
MS Research Town Hall is happening this World MS Day – May 27. There is no better day to raise awareness of MS…
MS Research Town Hall: Pre-Interview pt II with Dr. Ruth Ann Marrie
MS Research Town Hall is only 6 days away, and as the event draws near, I am getting more and more excited to…
MS Research Town Hall: Pre-Interview with Dr. Mark Freedman
This World MS Day (May 27), we invite you to take part in the MS Society of Canada’s MS Research Town Hall (formerly known as the…